Mark Lehmkuhle, CEO & Founder of Epitel: $20 Million Raised to Build the Future of Brain Health Monitoring

Welcome to another episode of Category Visionaries — the show that explores GTM stories from tech's most innovative B2B founders. In today’s episode, we’re speaking with Mark Lehmkuhle, CEO & Founder of Epitel, a brain health technology platform that has raised over $20 Million in funding. Here are the most interesting points from our conversation: Simplifying EEG Monitoring: Epitel has developed a wearable EEG sensor that makes brainwave monitoring easier for patients. Unlike traditional EEGs, which require extensive equipment and specialist interpretation, Epitel’s sensor offers a streamlined approach to detecting central nervous system disorders, especially seizures. Seizures vs. Epilepsy: While seizures are common, with 1 in 10 people experiencing one in their lifetime, not all seizures indicate epilepsy. Epitel focuses on seizure detection, addressing a broader spectrum of neurological conditions, not just epilepsy. Bootstrapping and Perseverance: Mark shared how the company started in 2008 with a small team and minimal resources, operating out of an artist colony with limited heating and air conditioning. The journey took years of grant funding and regulatory hurdles before reaching commercialization. Regulatory Pathway: Despite being a medical device, Epitel’s technology sits on the lower end of the FDA's regulatory spectrum, allowing them to move relatively quickly compared to more complex devices. They achieved FDA clearance with non-dilutive funding, a strategic milestone that paved the way for institutional investment. Data Collection Challenges: To train their AI, Epitel had to develop their own clean EEG dataset because hospitals typically delete such data post-diagnosis. This created a significant technical hurdle but also underscored the uniqueness of their solution. Future Vision: Mark envisions Epitel expanding beyond seizure monitoring into broader brain health applications. Long-term goals include creating a system for continuous brain health tracking, similar to continuous glucose monitors, potentially detecting early signs of conditions like Alzheimer’s or even alerting to stroke risks. // Sponsors: Front Lines — We help B2B tech companies launch, manage, and grow podcasts that drive demand, awareness, and thought leadership. www.FrontLines.io The Global Talent Co. — We help tech startups find, vet, hire, pay, and retain amazing marketing talent that costs 50-70% less than the US & Europe. www.GlobalTalent.co